AR042986A1 - Uso de una formulacion topica que comprende un agente dermatologico para la preparacion de un medicamento, composicion farmaceutica y un kit - Google Patents

Uso de una formulacion topica que comprende un agente dermatologico para la preparacion de un medicamento, composicion farmaceutica y un kit

Info

Publication number
AR042986A1
AR042986A1 ARP040100291A AR042986A1 AR 042986 A1 AR042986 A1 AR 042986A1 AR P040100291 A ARP040100291 A AR P040100291A AR 042986 A1 AR042986 A1 AR 042986A1
Authority
AR
Argentina
Prior art keywords
agent
use according
patch
dermatological agent
dermatological
Prior art date
Application number
Other languages
English (en)
Original Assignee
Teikoku Pharma Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of AR042986A1 publication Critical patent/AR042986A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Uso de una cantidad tópicamente efectiva de una formulación tópica que comprende un agente dermatológico; que se ocluye mediante una composición de hidrogel para parches a efectos de administrar dicho agente dermatológico a dicho huésped, comprendiendo dicha composición de hidrogel para parches: (i) un gel polímero soluble en agua; (ii) agua; (iii) un agente que retiene agua, e (iv) un agente reticulante, para la preparación de un medicamento, para administración tópica a un huésped. Seguidamente la formulación, topicalmente aplicada, del agente dermatológico es ocluida mediante un parche de hidrogel, siendo una de las características del parche de hidrogel que carece de un agente farmacéuticamente activo. También se proveen usos de dicha formulación tópica para la preparación de medicamentos para tratar una condición de enfermedad en un sujeto mediante la administración de un agente dermatológico al sujeto. Asimismo se proveen kits destinados a ser utilizados en la práctica de los métodos de la presente. Composiciones farmacéuticas de la presente encuentran una utilización en una variedad de aplicaciones diferentes. Reivindicación 5: El uso de acuerdo con la reivindicación 1, en el cual dicho agente dermatológico es un esteroide. Reivindicación 7: El uso de acuerdo con la reivindicación 1, en el cual dicho agente dermatológico es un no-esteroide. Reivindicación 12: El uso de acuerdo con la reivindicación 1, en el cual dicha composición de hidrogel para parches se halla presente sobre un soporte. Reivindicación 13: El uso de acuerdo con la reivindicación 12, en el cual dicho soporte es no poroso. Reivindicación 16: El uso de acuerdo con la reivindicación 1, en el cual dicho agente reticulante es seleccionado en el grupo consistente en : el gel seco de hidroxi de aluminio, el acetato dihidroxi de aluminio, el aluminometasilicato de magnesio, el hidróxido de aluminio, el metasilicato aluminato de magnesio, el silicato sintético de aluminio, el hidróxido de calcio, el amonio sulfato de aluminio, y el cloruro de calcio.
ARP040100291 2003-02-07 2004-01-30 Uso de una formulacion topica que comprende un agente dermatologico para la preparacion de un medicamento, composicion farmaceutica y un kit AR042986A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44557203P 2003-02-07 2003-02-07

Publications (1)

Publication Number Publication Date
AR042986A1 true AR042986A1 (es) 2005-07-13

Family

ID=32869382

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100291 AR042986A1 (es) 2003-02-07 2004-01-30 Uso de una formulacion topica que comprende un agente dermatologico para la preparacion de un medicamento, composicion farmaceutica y un kit

Country Status (9)

Country Link
US (3) US7887842B2 (es)
EP (1) EP1589917B1 (es)
JP (3) JP5232385B2 (es)
KR (2) KR20080035024A (es)
CN (1) CN100502821C (es)
AR (1) AR042986A1 (es)
ES (1) ES2387804T3 (es)
TW (2) TW200505508A (es)
WO (1) WO2004071469A2 (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040147187A1 (en) * 2003-01-23 2004-07-29 Rasor Allen C. Elastically deformable fabric with gel coated surface
US7887842B2 (en) * 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject
GB0307864D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
GB0307865D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US20050106221A1 (en) * 2003-11-14 2005-05-19 Nash Alan E. Kit for the treatment of a corn or a callus
EP1691745B1 (en) * 2003-12-11 2011-02-02 Teikoku Pharma USA, Inc. Methods and compositions for treating skin wounds
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
KR100798853B1 (ko) 2005-02-15 2008-01-28 (주)한국스티펠 레티노이드를 유효성분으로 하는 백반증 예방 및 치료용 약학적 조성물
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
US20070027152A1 (en) * 2005-07-27 2007-02-01 Clark Kathleen L Topical anti-pruritic compositions and methods of action of same
US20070027153A1 (en) * 2005-07-27 2007-02-01 Reeth Kevin M Topical skin-protectant and anti-pruritic compositions
JP5175041B2 (ja) * 2005-09-21 2013-04-03 コスメディ製薬株式会社 親水性粘着剤、それを用いた親水性皮膚外用粘着剤組成物および親水性貼付剤
CN100374117C (zh) * 2006-06-27 2008-03-12 邵丹 维丁乳膏及其制备工艺
US8389620B2 (en) * 2006-06-30 2013-03-05 Four Road Research Ltd. Dip forming latex composition containing crosslinking agent and dip formed article obtained therefrom
WO2008001764A1 (fr) * 2006-06-30 2008-01-03 Four Road Research Ltd. Agent de réticulation contenant une composition de latex et corps moulé réticulé correspondant
US7799352B2 (en) * 2006-08-09 2010-09-21 Korea Atomic Energy Research Institute Therapeutic hydrogel for atopic dermatitis and preparation method thereof
NO326950B1 (no) * 2006-09-20 2009-03-16 Pharma Medico Res Ltd Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks
KR20070080823A (ko) * 2007-01-31 2007-08-13 주식회사 티디에스팜 활성약물 함유 상처 치료용 하이드로겔 제제
WO2009084611A1 (ja) * 2007-12-28 2009-07-09 Zuiko Corporation かゆみ止めシート
US8541022B2 (en) * 2008-06-02 2013-09-24 Galderma S.A. Method of treating burns using avermectin compound
US8513225B2 (en) * 2008-10-03 2013-08-20 Winlind Skincare, Llc Composition and method for topical treatment of skin lesions
US8846646B2 (en) * 2008-10-03 2014-09-30 Winlind Skincare, Llc Topical treatment of skin infection
US20120238535A1 (en) * 2009-02-23 2012-09-20 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
US20110002918A1 (en) * 2009-03-06 2011-01-06 Photomedex Methods of treating diseased tissue
AU2011281399A1 (en) * 2010-07-22 2013-03-14 Ambicare Health Limited Disposable skin care device
CN101926833B (zh) * 2010-08-06 2012-01-04 云南白药集团无锡药业有限公司 水凝胶贴剂及其制备方法
HUE035584T2 (en) * 2011-01-21 2018-05-28 Igisu Co Ltd A therapeutic agent for the treatment of allopathy
US20120225018A1 (en) * 2011-03-03 2012-09-06 Nancy Josephine Polich Homeopathic therapeutic method and compositions
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
CN103127194A (zh) * 2011-11-22 2013-06-05 陕西盘龙制药集团有限公司 一种中药组合物
JP6044104B2 (ja) * 2012-04-23 2016-12-14 大日本印刷株式会社 シート状貼付用物品
US9211397B2 (en) * 2012-12-19 2015-12-15 Senju Usa, Inc. Patch for treatment of eyelid disease containing clobetasol
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
EP2968652B1 (en) 2013-03-13 2020-07-22 Avery Dennison Corporation Improving adhesive properties
CA2905587A1 (en) * 2013-03-15 2014-09-18 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment
WO2014200003A1 (ja) * 2013-06-12 2014-12-18 Tdk株式会社 リチウムイオン二次電池用負極およびこれを用いたリチウムイオン二次電池
JP6232788B2 (ja) * 2013-07-05 2017-11-22 大日本印刷株式会社 貼付用シート
JP6444305B2 (ja) * 2013-08-09 2018-12-26 帝國製薬株式会社 ベラプロスト含有貼付剤
JP2015090845A (ja) * 2013-11-07 2015-05-11 Tdk株式会社 リチウムイオン二次電池用負極活物質、リチウムイオン二次電池用負極およびリチウムイオン二次電池
CN104622793A (zh) * 2013-11-12 2015-05-20 张峰 一种缓解季节性眼睛过敏的水凝胶贴剂
KR20170023776A (ko) * 2014-02-26 2017-03-06 루마 세러퓨틱스 인코포레이티드 자외선 광선 치료 장치들 및 방법들
CN103989552B (zh) * 2014-05-07 2015-10-28 江苏达胜伦比亚生物科技有限公司 一种医用水凝胶凉贴
CN104000830B (zh) * 2014-05-19 2017-02-01 中国人民解放军第二军医大学 一种复方克罗米通制剂及其应用
EP3209389B1 (en) 2014-10-21 2019-10-02 The Procter and Gamble Company Kit for improving skin appearance
EP3250258A4 (en) 2015-01-28 2018-09-05 Chrono Therapeutics, Inc. Drug delivery methods and systems
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
EP3365067B1 (en) 2015-10-22 2019-11-20 The Procter and Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
WO2017070078A1 (en) 2015-10-22 2017-04-27 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
CN109310527A (zh) 2016-02-09 2019-02-05 鲁玛治疗公司 用于通过光疗法来治疗牛皮癣的方法、组合物和设备
US10371610B2 (en) 2016-02-23 2019-08-06 Noul Co., Ltd. Contact-type patch, staining method using the same, and manufacturing method thereof
KR20170099737A (ko) 2016-02-23 2017-09-01 노을 주식회사 접촉식 염색 패치 및 이를 이용하는 염색 방법
CN106309489B (zh) * 2016-09-28 2020-07-21 贵州特力达纳米碳素科技有限公司 一种用于皮肤消炎的药贴及其制备方法
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
US10751265B2 (en) 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
EP3565642A1 (en) 2017-01-09 2019-11-13 The Procter and Gamble Company Barrier patch with soluble film and methods of improving skin appearance
US11383084B2 (en) * 2017-04-27 2022-07-12 Palo Alto Investors Treatment of dermatological conditions via neuromodulation
CN107028874A (zh) * 2017-06-07 2017-08-11 首都医科大学附属北京朝阳医院 外用药膏
EP3641952B1 (en) 2017-06-22 2023-08-02 The Procter & Gamble Company Beauty care films including a water-soluble layer and a vapor-deposited coating
EP3768249B1 (en) 2018-03-19 2024-04-17 The Procter & Gamble Company Method of making a barrier patch with soluble film
CN108514562A (zh) * 2018-03-22 2018-09-11 郭忠营 一种治疗白癫风乳膏及其制备方法
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
KR101956104B1 (ko) * 2018-08-02 2019-03-12 (주)잇츠한불 트래거캔스 검을 포함하는 하이드로겔 조성물
KR102184519B1 (ko) * 2020-06-29 2020-11-30 손근형 아토피 피부염용 습포

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE31985B1 (en) 1967-03-29 1973-03-07 Lilly Co Eli Medicated adhesive tape
US3891757A (en) * 1971-11-11 1975-06-24 Alza Corp Anaesthetic topical and percutaneous administration with selected promoters
US4009282A (en) * 1973-12-17 1977-02-22 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with prostaglandins
JPS56154421A (en) * 1980-05-01 1981-11-30 Nitto Electric Ind Co Ltd Crosslinkable aqueous gel used in medical treatment
US4917890A (en) * 1985-06-28 1990-04-17 Carrington Laboratories, Inc. Processes for preparation of aloe products, products produced thereby and compositions thereof
DE3224382A1 (de) * 1982-06-30 1984-01-12 Beiersdorf Ag, 2000 Hamburg Verbandmaterial auf hydrogelbasis und verfahren zu dessen herstellung
US4788061A (en) * 1985-07-05 1988-11-29 Shore Ronald N Extended occlusive treatment of skin disorders
US4909244B1 (en) * 1986-11-26 1994-07-05 Kendall & Co Hydrogel wound dressing
GB8705985D0 (en) * 1987-03-13 1987-04-15 Geistlich Soehne Ag Dressings
DE3827561C1 (es) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
DE4006628A1 (de) 1990-03-06 1990-11-22 Bernd Dr Med Ditter Verfahren zur oertlichen daueranwendung von antiallergischen, entzuendungshemmenden und juckreizstillenden hautmitteln
DE4007668A1 (de) * 1990-03-10 1991-09-12 Beiersdorf Ag Hydrogelschaeume und verfahren zu deren herstellung
EP0525267A3 (en) * 1991-08-02 1993-04-21 Ferndale Laboratories, Inc. Prolonged occlusion treatment system
AU3070892A (en) * 1991-11-12 1993-06-15 Nepera, Inc. Adhesive hydrogels having extended use lives and process for the preparation of same
NZ250994A (en) 1993-05-27 1995-09-26 Ndm Acquisition Corp Wound dressing comprising a hydrogel layer bound to a porous backing layer which is bound to a thin film layer by adhesive
US5695777A (en) * 1994-05-10 1997-12-09 Medtronic, Inc. Absorptive wound dressing for wound healing promotion
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US5843936A (en) 1996-06-28 1998-12-01 Bernstein; Lawrence R. Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes
DE69801820T2 (de) 1997-01-09 2002-04-11 Bifodan A/S, Hundested Verwendung von Dichlorobenzyl Alkohol zur Herstellung einer Zusammenstellung zur topischen Behandlung von Entzündungen
US6224896B1 (en) 1997-07-28 2001-05-01 Curlor Healthcare Technologies, Llc Composition and process for the treatment of epidermal traumas such as decubitus ulcers
JPH11228340A (ja) * 1998-02-12 1999-08-24 Nitto Denko Corp 化粧用ゲルシート
US5902827A (en) * 1998-04-17 1999-05-11 Cell Pathways Method for treating patients with psoriasis by administering substituted sulfonyl indenyl acetic acids, esters and alcohols
IT1309588B1 (it) * 1999-03-05 2002-01-24 Altergon Sa Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.
US6348212B2 (en) * 1999-05-18 2002-02-19 Lectec Corporation Treating traumatic burns or blisters of the skin
US6455065B1 (en) * 1999-05-18 2002-09-24 Lectec Corporation Therapeutic method for treating acne or isolated pimples and adhesive patch therefor
US6147102A (en) 1999-10-26 2000-11-14 Curatek Pharmaceuticals Holding, Inc. Clonidine preparations
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
KR20010096776A (ko) 2000-04-14 2001-11-08 이영길 2종 이상의 수용성 고분자를 포함하는 시이트형하이드로겔 팩제 및 그의 제조방법
ATE286408T1 (de) * 2000-10-23 2005-01-15 Tissuemed Ltd Selbstklebende, hydratierbare matrix für therapeutische anwendungen
EP1245240A1 (en) * 2001-03-30 2002-10-02 The Procter & Gamble Company Skin-compatible hydrogel adhesives and personal care products containing them
JP2003188149A (ja) 2001-12-17 2003-07-04 Hitachi Kokusai Electric Inc 半導体装置の製造方法
JP2006503072A (ja) 2002-10-02 2006-01-26 ノルディック ワクチン テクノロジー アクティーゼルスカブ ワクチン接種用組成物
AU2004208596C1 (en) 2003-01-28 2012-01-19 Teikoku Seiyaku Co., Ltd Thin aqueous cataplasm
US7887842B2 (en) * 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject

Also Published As

Publication number Publication date
CN100502821C (zh) 2009-06-24
TW200505508A (en) 2005-02-16
TW201043270A (en) 2010-12-16
US8449913B2 (en) 2013-05-28
US20130115268A1 (en) 2013-05-09
EP1589917B1 (en) 2012-06-27
JP2006517224A (ja) 2006-07-20
US7887842B2 (en) 2011-02-15
EP1589917A2 (en) 2005-11-02
JP2014237712A (ja) 2014-12-18
CN1747703A (zh) 2006-03-15
US20100203107A1 (en) 2010-08-12
JP5635829B2 (ja) 2014-12-03
EP1589917A4 (en) 2006-03-29
ES2387804T3 (es) 2012-10-02
JP5232385B2 (ja) 2013-07-10
US9023392B2 (en) 2015-05-05
US20040202706A1 (en) 2004-10-14
KR20050096973A (ko) 2005-10-06
JP2010280696A (ja) 2010-12-16
WO2004071469A3 (en) 2004-12-29
KR20080035024A (ko) 2008-04-22
WO2004071469A2 (en) 2004-08-26
KR100853436B1 (ko) 2008-08-21

Similar Documents

Publication Publication Date Title
AR042986A1 (es) Uso de una formulacion topica que comprende un agente dermatologico para la preparacion de un medicamento, composicion farmaceutica y un kit
ES2317998T3 (es) Composicion topica efervescente.
ES2700869T3 (es) Composición liofilizada
ES2272586T3 (es) Preparacion con vehiculo farmaceutico aplicable a superficies de mucosas.
JP6425767B2 (ja) ロキソプロフェンを含有する医薬組成物＜弐＞
BRPI0713182A2 (pt) usos de adapaleno de um de seus sais farmaceuticamente aceitáveis, kit e produto
JP2016500095A5 (es)
BRPI0519748A2 (pt) preparaÇço de curativo para resfriamento tàpico
BRPI0611107A2 (pt) composições para administração de medicamentos
ES2758349T3 (es) Composición para el tratamiento de lesiones de la piel y/o de las uñas
BRPI0508933A (pt) composições para entrega tópica
PT96550A (pt) Processo para a libertacao percutanea de ibuprofeno utilizando gel hidro-alcoolico
CN106604717B (zh) 局部用双氯芬酸钠组合物
BR112020008077A2 (pt) composição farmacêutica, composição farmacêutica para aplicação tópica e uso de uma composição tópica
ES2394169T3 (es) Uso de quitosanos para el tratamiento de enfermedades inflamatorias de las uñas
JPH0338250B2 (es)
ES2727801T3 (es) Procedimiento para la fabricación de cuerpos moldeados porosos con contenido en alginato
ES2457519T3 (es) Pasta a base de agua que contiene diclofenaco sódico
JP2011088930A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JPH08188527A (ja) シート状パック剤
JPWO2003002075A1 (ja) シート状パック剤
JP2019081755A (ja) 組成物
JP2013163681A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP5164438B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
ES2751100T3 (es) Composición filmógena y su uso para el tratamiento del herpes

Legal Events

Date Code Title Description
FA Abandonment or withdrawal